Oxytocin reference standards will now be allowed to be imported exclusively for the purpose of test and analysis; says Ministry of Health and Family Welfare by comtideging1971 | Jan 29, 2020 | OPS, Pharmaceuticals, statesIn a Notification dated 27th January, 2020 the Ministry of Health and Family Welfare (“Ministry’)... Read More
Delhi HC stays Centre’s order preventing manufacture and sale of Oxytocin by Private manufacturers for a period of 1 month i.e. till 31.09.2018 by Lexplosion | Sep 6, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Delhi High Court has imposed a stay on the Central Government order banning the manufacture... Read More
Ministry of Health and Family Welfare invites comments on its plan to re-classify ‘Oxytocin as a Schedule H1 category Drug’ till 17th August, 2018 by Lexplosion | Aug 13, 2018 | EHS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) proposes to omit oxytocin from the category... Read More
Ministry of Health and Family Welfare imposes ban on manufacturing of Oxytocin by private manufacturers effective 1.07.2018 by Lexplosion | Jul 11, 2018 | OPS, Pharmaceuticals, statesIn a Press Release dated 27th June, 2018, the Ministry of Health and Family Welfare has made the... Read More
CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin by Lexplosion | May 28, 2018 | Healthcare, OPS, Pharmaceuticals, statesAn Office Memorandum dated 21st May, 2018, has been issued by the Central Drugs Standard Control... Read More